{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T08:57:49Z","timestamp":1767171469955,"version":"build-2238731810"},"reference-count":10,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,6]]},"DOI":"10.1182\/blood.2023020393","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T11:51:09Z","timestamp":1690545069000},"page":"4-6","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the methylome to improve CLL outcome"],"prefix":"10.1182","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8505-7430","authenticated-orcid":false,"given":"John G.","family":"Gribben","sequence":"first","affiliation":[{"name":"1Barts Cancer Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"1","key":"2023072815504773400_bib1","first-page":"44","article-title":"Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia","volume":"142","author":"Jiang","year":"2023","journal-title":"Blood"},{"issue":"2","key":"2023072815504773400_bib2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1182\/blood-2015-06-651125","article-title":"Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial","volume":"127","author":"Fischer","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2023072815504773400_bib3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ccell.2014.10.012","article-title":"Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia","volume":"26","author":"Landau","year":"2014","journal-title":"Cancer Cell"},{"issue":"7757","key":"2023072815504773400_bib4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-019-1198-z","article-title":"Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia","volume":"569","author":"Gaiti","year":"2019","journal-title":"Nature"},{"issue":"10","key":"2023072815504773400_bib5","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"2023072815504773400_bib6","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1073\/pnas.0901166106","article-title":"E(mu)-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction","volume":"106","author":"Gorgun","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2023072815504773400_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1182\/blood-2015-02-626754","article-title":"Mechanisms of PD-L1\/PD-1-mediated CD8\u00a0T-cell dysfunction in the context of aging-related immune defects in the E\u03bc-TCL1 CLL mouse model","volume":"126","author":"McClanahan","year":"2015","journal-title":"Blood"},{"issue":"32","key":"2023072815504773400_bib8","doi-asserted-by":"crossref","first-page":"13433","DOI":"10.1073\/pnas.0906455106","article-title":"Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia","volume":"106","author":"Chen","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2023072815504773400_bib9","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/ajh.26367","article-title":"Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures","volume":"96","author":"Hallek","year":"2021","journal-title":"Am J Hematol"},{"key":"2023072815504773400_bib10","doi-asserted-by":"crossref","first-page":"1120911","DOI":"10.3389\/fphar.2023.1120911","article-title":"LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials","volume":"14","author":"Noce","year":"2023","journal-title":"Front Pharmacol"}],"updated-by":[{"DOI":"10.1182\/blood.2023022123","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000}}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/1\/4\/2067175\/blood_bld-2023-020393-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/1\/4\/2067175\/blood_bld-2023-020393-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T11:51:19Z","timestamp":1690545079000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/142\/1\/4\/496547\/Targeting-the-methylome-to-improve-CLL-outcome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,7,6]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023020393","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,6]]}}}